Atrion Corporation (ATRI)
NASDAQ: ATRI · IEX Real-Time Price · USD
395.01
-3.96 (-0.99%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Atrion Revenue

In the year 2023, Atrion had annual revenue of $169.33M, a decrease of -7.73%. Revenue in the quarter ending December 31, 2023 was $43.58M with 1.70% year-over-year growth.

Revenue (ttm)
$169.33M
Revenue Growth
-7.73%
P/S Ratio
4.11
Revenue / Employee
$237,817
Employees
712
Market Cap
695.20M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023169.33M-14.18M-7.73%
Dec 31, 2022183.51M18.50M11.21%
Dec 31, 2021165.01M17.42M11.80%
Dec 31, 2020147.59M-7.48M-4.82%
Dec 31, 2019155.07M2.62M1.72%
Dec 31, 2018152.45M5.85M3.99%
Dec 31, 2017146.60M3.11M2.17%
Dec 31, 2016143.49M-2.25M-1.54%
Dec 31, 2015145.73M4.97M3.53%
Dec 31, 2014140.76M8.77M6.64%
Dec 31, 2013131.99M12.93M10.86%
Dec 31, 2012119.06M1.36M1.15%
Dec 31, 2011117.70M9.14M8.41%
Dec 31, 2010108.57M7.93M7.88%
Dec 31, 2009100.64M4.75M4.95%
Dec 31, 200895.90M7.36M8.31%
Dec 31, 200788.54M7.52M9.28%
Dec 31, 200681.02M8.93M12.39%
Dec 31, 200572.09M6.01M9.09%
Dec 31, 200466.08M3.28M5.22%
Dec 31, 200362.80M3.27M5.49%
Dec 31, 200259.53M1.93M3.35%
Dec 31, 200157.61M6.16M11.97%
Dec 31, 200051.45M1.53M3.07%
Dec 31, 199949.92M6.52M15.02%
Dec 31, 199843.40M13.12M43.33%
Dec 31, 199730.28M8.16M36.87%
Dec 31, 199622.12M10.40M88.76%
Dec 31, 199511.72M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pediatrix Medical Group 1.99B
Accolade 388.49M
HealthStream 279.06M
Cytek Biosciences 193.02M
OrthoPediatrics 148.73M
BioLife Solutions 143.27M
PureTech Health 15.62M
Autolus Therapeutics 1.70M
Revenue Rankings